Prostate Specific Membrane Antigen (PSMA) Imaging for Detection of Residual and Metastatic Prostate Cancer | MicrobiomeTrials← Back to trialsNCT07593079
Prostate Specific Membrane Antigen (PSMA) Imaging for Detection of Residual and Metastatic Prostate Cancer
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-10-31Est. Completion: 2027-11-14
Enrollment target: 20 participants Locations- Washington University School of Medicine, St Louis, Missouri, United States
Other microbiome trials you might be interested in
Prostate Cancer
Prostate cancer is the most frequently diagnosed cancer among men over 50 years old in Western societies, with an incide…
Hackensack, United StatesCompleted Oct 1, 2026
Recurrent Prostate CancerProstate Cancer
Background:
Biochemically recurrent prostate cancer (BCR) occurs when prostate-specific antigen (PSA) levels in the blo…
Bethesda, United StatesEst. completion Jan 30, 2029